Device Firms Dig In Against Baucus Fee, Despite Class I, Revenue Exceptions

The device industry lobbying machine has accelerated in opposition to Sen. Max Baucus' plan for a $40 billion fee on manufacturers in the lead up to Finance Committee health reform mark-up sessions this week

More from Archive

More from Medtech Insight